EA201490783A1
(ru )
2014-07-30
ТАБЛЕТКА, ВКЛЮЧАЮЩАЯ В СЕБЯ 7-[4-(4-БЕНЗО[b]ТИОФЕН-4-ИЛ-ПИПЕРАЗИН-1-ИЛ)БУТОКСИ]-1Н-ХИНОЛИН-2-ОН ИЛИ ЕГО СОЛЬ
AU2019268075A1
(en )
2019-12-12
Pharmaceutical compositions comprising dimethyl fumarate
MY183536A
(en )
2021-02-25
Pharmaceutical compositions comprising azd9291
TR201906936T4
(tr )
2019-06-21
Protein kinaza yönelik inhibitör aktiviteye sahip tiyenopirimidin türevleri.
MX2009009703A
(es )
2010-03-03
Preparacion solida que comprende 2-[[6-[(3r)-3-amino-1-piperidinil ]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-4-fluoro benzonitrilo.
EP4541422A3
(en )
2025-06-25
Quinoline derivatives as alpha4beta7 integrin inhibitors
MX2023014946A
(es )
2024-02-20
Composicion farmaceutica para administracion oral que comprende derivado de aminopirimidina o su sal.
EA200971069A1
(ru )
2010-04-30
Метаболиты производных (тио)карбомоилциклогексана
PH12019501873A1
(en )
2020-06-15
Pharmaceutical composition
WO2016126085A3
(ko )
2016-11-03
헤테로 고리 화합물 및 그를 포함하는 약제학적 조성물
EA201391018A1
(ru )
2013-11-29
Препараты иммуносупрессантов
RU2014138035A
(ru )
2016-04-10
Твердая фармацевтическая композиция, содержащая 1-(3-(2-(1-бензотиофен-5-ил)этокси)пропил)азетидин-3-ол или его соль
PH12019501288A1
(en )
2019-12-02
Novel preparation containing benzimidazole derivative
NZ745210A
(en )
2019-08-30
Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor
MX389761B
(es )
2025-03-20
Una composicion farmaceutica que comprende rosuvastatina y ezetimibe y un metodo de preparacion de la misma.
JP2016108327A5
(th )
2017-03-09
EP2871187A4
(en )
2015-09-23
A NEW CONNECTION OR PHARMACEUTICALALLY SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS AN ACTIVE SUBSTANCE
TN2014000177A1
(en )
2015-09-30
Immediate release 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-[5-(4-methyl- 1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide formulation
TR201009394A2
(tr )
2012-06-21
Geliştirilmiş montelukast formülasyonları.
BR112015004091A2
(pt )
2017-07-04
formulação de cápsula de compósito farmacêutico que compreende irbesartan e inibidor de hmg-coa redutase
TH148341A
(th )
2016-04-01
ยาเม็ดซึ่งประกอบรวมด้วย 7-[4-(4-เบนโซ[b]ไธโอเฟน-4-อิล-ไพเพอราซิน-1-อิล)บิวทอกซิ]-1H-ควิโนลิน-2-โอน หรือเกลือของมัน
EP3404020A4
(en )
2020-01-01
PYRIDINOL DERIVATIVE OR PHARMACEUTICALLY SAFE SALT THEREOF AND PHARMACEUTICAL COMPOSITION THEREFORE AS AN ACTIVE SUBSTANCE
JP2015221782A5
(th )
2016-10-20
NZ627991A
(en )
2016-03-31
Liquid formulations of hypoglycaemic sulphonamides
MX2019005005A
(es )
2019-06-20
Tableta de liberacion extendida que comprende un farmaco de perdida de peso.